Ballaho, Noridzna Shanaia M.

HRN: 25-18-95  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2024
CEFUROXIME 750MG (VIAL)
10/25/2024
11/01/2024
IV
350mg
Q 8 Hours
AGE With Moderate Dehydration
Waiting Final Action 
10/25/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/25/2024
10/31/2024
IVT
100mg
Q8
E.Histolytica
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: